Medicine News and Research

RSS

Penn Medicine to participate in PathCentral Pathology Network

PathCentral, a technology-enabled company dedicated to the success of the international pathology community, announced today that Penn Medicine will participate in the PathCentral Pathology Network, the specialty's most comprehensive online information exchange and digital consultation forum.

17 Jun 2013

Researchers produce first genome-wide investigation of cap-independent translation

Because of their central importance to biology, proteins have been the focus of intense research, particularly the manner in which they are produced from genetically coded templates-a process commonly known as translation. While the general mechanism of translation has been understood for some time, protein synthesis can initiate by more than one mechanism. One of the least well understood mechanisms is known as cap-independent translation.

17 Jun 2013

Mount Sinai researchers present several new studies at ENDO 2013

Researchers from the Icahn School of Medicine at Mount Sinai will present several new studies at ENDO 2013, The Endocrine Society's Annual Meeting & Expo from June 15-18 in San Francisco.

17 Jun 2013

Ibrutinib monotherapy shows efficacy in patients with MCL or DLBCL

Pharmacyclics, Inc. today announced the results of two separate Phase 2 studies suggesting that ibrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, showed efficacy when used as a monotherapy in patients with relapsed/refractory mantle cell lymphoma or diffuse large B-cell lymphoma.

17 Jun 2013

Ambrx, ZMC partner to develop and commercialize ARX788 for treatment of Her2-positive breast cancer

Ambrx and Zhejiang Medicine Co. Ltd. today announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced internally developed site-specific antibody drug conjugate targeting Her2-positive breast cancer.

17 Jun 2013

U-M receives $1.1M grant from AMA to provide innovative ways of training new physicians

For 164 years, the University of Michigan Medical School has led the nation in innovative ways of training new physicians.

15 Jun 2013

Study shows patients with avascular necrosis have turned to stem cell therapy for aid

Stem cells have long been touted as the next big thing. Well just maybe, it is here. According to Dr. Dennis Lox, some patients with a disorder of the bone called avascular necrosis (AVN), have turned to stem cell therapy for aid.

15 Jun 2013

Dosimetry based on 3-D medical images estimates possible dose for targeted RIT in blood cancer patients

Outcomes can be bleak for non-Hodgkin lymphoma (NHL), a cancer that develops in the white blood cells of the immune system. Accurate estimation of radiation absorbed dose in radioimmunotherapy (RIT) based on state-of-the-art 3D imaging could lead to more personalized and effective treatments to improve patients' chances of living longer without progression of their cancer, say researchers at the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting.

15 Jun 2013

Penn researchers develop variant of mu opioid painkiller receptor to overcome side effects

Opioids, such as morphine, are still the most effective class of painkillers, but they come with unwanted side effects and can also be addictive and deadly at high doses. Designing new pain-killing drugs of this type involves testing them on their corresponding receptors, but access to meaningful quantities of these receptors that can work in experimental conditions has always been a limiting factor.

15 Jun 2013

Amedra Pharmaceuticals re-launches single-dose epinephrine auto-injector, Adrenaclick

Amedra Pharmaceuticals LLC has announced re-launch of Adrenaclick®, a single-dose epinephrine auto-injector, for the emergency treatment of life threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. Adrenaclick® will be available as a two-pack carton in both 0.15 mg and 0.30 mg strengths.

15 Jun 2013

Pfizer receives $2.15 billion settlement from Teva and Sun for patent-infringement damages

Pfizer Inc. announced today a $2.15 billion settlement reached with Teva Pharmaceuticals Industries, Limited and Sun Pharmaceutical Industries, Limited for patent-infringement damages resulting from their "at-risk" launches of generic Protonix® in the United States.

15 Jun 2013

Irene Pollin gifts $10 million to the Ciccarone Center for Prevention of Heart Disease

Irene Pollin, a passionate health advocate and founder of a national organization devoted to heart disease prevention in women, has made a $10 million gift to the Ciccarone Center for the Prevention of Heart Disease.

15 Jun 2013

Study seeks answers for why youth baseball pitching injuries continue to rise despite pitching limits

After three years of research, a multicenter, national research study led by Beaumont orthopedic surgeon and sports medicine specialist, Joseph Guettler, M.D., may have some answers as to why youth baseball pitching injuries continue to rise despite the implementation of nationally recommended pitching limits.

15 Jun 2013

Anatomy of a Hospital: New book chronicles history of nation's oldest hospital for orthopedics

With 537 pages and 150 photographs, "Anatomy of a Hospital" chronicles the history of the nation's oldest hospital for orthopedics, from its beginnings in a doctor's home to help destitute children with disabilities to the premier hospital it has become today.

15 Jun 2013

Specialists working in migraine and headache share scientific advances at International Headache Congress

Researchers and clinicians worldwide working in migraine, headache and brain injury share the field's latest scientific advances at the International Headache Congress, hosted by the International Headache Society and the American Headache Society.

15 Jun 2013

Research: Women with urinary incontinence are more likely to suffer depression

Research from the University of Adelaide shows middle-aged women are more likely to suffer depression from a common medical problem that they find too embarrassing to talk about: urinary incontinence.

15 Jun 2013

RUSM makes history by awarding medical doctor degree to 10,000th student

History was made at the Ross University School of Medicine commencement ceremony on June 14 when the School's 10,000th graduate was awarded a medical degree. The graduation was held at the Bank United Center in Coral Gables, Fla.

15 Jun 2013

HandsFree system helps analyze next generation sequencing data

In the early 1990s, an international effort was launched by the U.S. Department of Energy and the National Institutes of Health to sequence the human genome. The project took 13 years, involved many scientists in several countries, and cost $2.7 billion (in FY 1991) dollars.

15 Jun 2013

AIFA approves pricing and reimbursement conditions for InterMune's Esbriet

InterMune, Inc. today announced that the Board of the Italian Drug Agency has approved the pricing and reimbursement conditions for Esbriet (pirfenidone), and that the agreement has been published in the Official Gazette, the official journal of the government of Italy.

15 Jun 2013

Elcelyx Therapeutics' posters related to NewMet to be presented at ADA's 73rd Scientific Sessions

Elcelyx Therapeutics today announced that the company and principal investigator Ralph A. DeFronzo, M.D. will present posters related to NewMet, a delayed-release formulation of generic metformin, at the 73rd Scientific Sessions of the American Diabetes Association in Chicago, IL.

15 Jun 2013

Medicine News and Research

Penn Medicine to participate in PathCentral Pathology Network

Researchers produce first genome-wide investigation of cap-independent translation

Mount Sinai researchers present several new studies at ENDO 2013

Ibrutinib monotherapy shows efficacy in patients with MCL or DLBCL

Ambrx, ZMC partner to develop and commercialize ARX788 for treatment of Her2-positive breast cancer

U-M receives $1.1M grant from AMA to provide innovative ways of training new physicians

Study shows patients with avascular necrosis have turned to stem cell therapy for aid

Dosimetry based on 3-D medical images estimates possible dose for targeted RIT in blood cancer patients

Penn researchers develop variant of mu opioid painkiller receptor to overcome side effects

Amedra Pharmaceuticals re-launches single-dose epinephrine auto-injector, Adrenaclick

Pfizer receives $2.15 billion settlement from Teva and Sun for patent-infringement damages

Irene Pollin gifts $10 million to the Ciccarone Center for Prevention of Heart Disease

Study seeks answers for why youth baseball pitching injuries continue to rise despite pitching limits

Anatomy of a Hospital: New book chronicles history of nation's oldest hospital for orthopedics

Specialists working in migraine and headache share scientific advances at International Headache Congress

Research: Women with urinary incontinence are more likely to suffer depression

RUSM makes history by awarding medical doctor degree to 10,000th student

HandsFree system helps analyze next generation sequencing data

AIFA approves pricing and reimbursement conditions for InterMune's Esbriet

Elcelyx Therapeutics' posters related to NewMet to be presented at ADA's 73rd Scientific Sessions

Everything there is to know about biosimilars eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News